Glenmark Pharmaceuticals Ltd.

GLENMARK Share PricePharmaceuticals & Drugs

₹1,973.8

7.9 (0.4%)

As on December 4, 2025

Exchange Scrips: BSE532296NSEGLENMARKISININE935A01035

Market Cap ₹ 55,752 Cr

P/E Ratio 53.19

Dividend Yield 0.13 %

Performance

Market performance

Open1,960.1

High1,984.9

Volumes4,14,550

Prev1,973.8

Low1,960.1

As on2025-12-04

Historical performance

1 Year High2,284.8

3 Year High2,284.8

5 Year High2,284.8

1 Year Low1,275.5

3 Year Low369.05

5 Year Low348.5

Fundamentals

Company Valuation

Market Cap (₹Cr)

55,752

Face Value (₹)

P/E Ratio

53.19

Dividend Yield

0.13 %

Investment Returns

1 Year

27.5%

3 Years

353.8%

5 Years

292.2%

10 Years

106.7%

Technicals

Indicators	Value	Signal
5-DMA	1,961.24	Bullish
10-DMA	1,923.96	Bullish
20-DMA	1,887.64	Bullish
50-DMA	1,899.57	Bullish
100-DMA	1,984.79	Bearish
200-DMA	1,737.97	Bullish

Shareholding Pattern

Field	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Promoters	6	6	6	6	6
Foreign Investors	---	---	---	---	---
Domestic Investors	6	6	6	6	6
Public Investors	198783	190204	192718	195053	193943
Government	4	4	4	3	3

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

Negative

Neutral

Positive

The stock has a PE ratio of 53.19.
3Y Stock Price CAGR of the stock is 65.5.
The stock has a beta of 0.6.
In the last financial year, the company had an EBITDA of ₹24651 Million.
The company generated revenue of ₹133217 Million in the previous financial year.

Glenmark Pharmaceuticals Ltd.

1973.87.9 (0.4%)

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1277829.9

No. of Shares: 647 (Approx)

Performance:27.8%

P/L: ₹277829.9

Top Gainers